Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants [NA]
A recruiting study sponsored by Jonsson Comprehensive Cancer Center aims to use advocates and supporters to boost lung cancer screening rate…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial [Phase 2]
Phase 2 trial evaluating imlunestrant in combination with abemaciclib for estrogen receptor-positive breast cancer with minimal residual dis…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer [Phase 3]
This Phase 3 trial from Memorial Sloan Kettering Cancer Center is testing a comprehensive prevention program to reduce lymphedema after axil…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC [Phase 2]
Phase 2 neoadjuvant trial (PaCT) for locally advanced triple-negative breast cancer has completed with results posted on 2025-11-06.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Mirai-MRI: Validation of AI Models for Breast Cancer Risk [NA]
Ongoing recruitment for Mirai-MRI, a study validating AI-based MRI models to assess breast cancer risk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating concurrent WOKVAC vaccination, chemotherapy, and HER2-targeted monoclonal antibody therapy before surgery …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
This clinical trial update covers research on mechanisms, predictors, and social determinants of cardiotoxicity in breast cancer; the study …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Axillary Reverse Mapping [Phase 2]
Update on a Phase 2 clinical trial of axillary reverse mapping for breast cancer, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial [NA]
Clinical trial update for the RADCOMP trial comparing proton therapy vs photon therapy in non-metastatic breast cancer; the study is current…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. [Phase 1, Phase 2]
A Phase I/II dose-finding study assessing [177Lu]Lu-NeoB in combination with capecitabine for GRPR+, ER+, HER2-negative metastatic breast ca…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Multi-center MRD Registry for Inflammatory Breast Cancer
A multi-center registry study evaluating minimal residual disease in inflammatory breast cancer, currently recruiting at MD Anderson Cancer …
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast [NA]
A USC-sponsored clinical trial evaluating targeted intra-operative radiotherapy for ductal carcinoma in situ of the breast has terminated; r…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients [NA]
The NAVAH study update reports on its impact on completing radiation therapy among Black patients with breast cancer and prostate cancer; th…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer [NA]
An update on a Mount Sinai–led clinical trial aimed at improving access to supportive services for women of color with metastatic breast can…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial [Phase 2]
This document describes a Phase II trial (RAPS) evaluating Response Adaptive Ablative Pre-operative SPBI with non-operative sentinel lymph n…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer [Phase 3]
This update describes a Phase 3 trial evaluating a shorter chemo-immunotherapy regimen that omits anthracyclines for early-stage triple-nega…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY [Phase 2]
Phase 2 clinical trial DAANCE for chemotherapy-induced peripheral neuropathy in breast cancer patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: RCT Implant Based Breast Reconstruction [NA]
This entry reports the completion of a randomized controlled trial evaluating implant-based breast reconstruction after mastectomy. The stud…
-
EMA approval · 2025-11-04EMA Authorised: Truqap (capivasertib) — AstraZeneca AB
The European Medicines Agency authorised Truqap (capivasertib) for breast cancer. Marketing authorization holder: AstraZeneca AB (decision d…
-
EMA approval · 2025-11-04EMA Authorised: Piqray (alpelisib) — Novartis Europharm Limited
The European Medicines Agency authorised Piqray (alpelisib) by Novartis Europharm Limited for breast cancer, with decision dated 02 October …
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors [Phase 2]
Phase 2 clinical trial evaluating flibanserin for hypoactive sexual desire disorder in breast cancer survivors on tamoxifen or aromatase inh…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Genomic Structural Variation in Cancer Susceptibility
This clinical trial update discusses ongoing research on genomic structural variation in cancer susceptibility and lists several cancer cond…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks [Phase 4]
Phase 4 clinical trial evaluating whether preoperative PECS-II blocks improve post-mastectomy recovery compared with intraoperative pectoral…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. [Phase 2]
This update presents efficacy and safety results from a Phase 2 trial of ribociclib in pre- and postmenopausal Chinese women with HR-positiv…